Mania as a possible complication of immunotherapy

Abstract

Immunotherapy is still a relatively new cancer therapy and this article serves as a reminder to psychiatric teams to consider immunotherapy as a possible factor in psychiatric presentations. Here, the authors present the case of a woman who developed signs of personality changes and acute mania after treatment with checkpoint inhibitors ipilimumab and nivolumab